| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/06/2002 | EP1183253A1 C7 ester substituted taxanes as antitumor agents |
| 03/06/2002 | EP1183252A1 New pharmaceutically active compounds |
| 03/06/2002 | EP1183250A1 Semi-synthesis of paclitaxel using dialkyldichlorosilanes |
| 03/06/2002 | EP1183241A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183237A1 Novel antioxidants, preparation methods and uses |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183231A1 Cytofectin dimers and methods of use thereof |
| 03/06/2002 | EP1183228A2 Esters of l-carnitine or alkanoyl l-carnitines |
| 03/06/2002 | EP1183050A2 Method for producing an injectable medicament preparation |
| 03/06/2002 | EP1183049A2 Modification of biological elements |
| 03/06/2002 | EP1183047A2 Pharmaceutical preparation |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP1183039A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
| 03/06/2002 | EP1183033A1 Pyrrolotriazine inhibitors of kinases |
| 03/06/2002 | EP1183023A1 Use of verapamil and verapamil derivatives for producing medicaments with an inhibiting effect on beta-glucuronidase in human tissue |
| 03/06/2002 | EP1182929A1 Osteonectin based toxic gene therapy for the treatment of calcified tumors and tissues |
| 03/06/2002 | EP1003534B1 Reovirus for the treatment of neoplasia |
| 03/06/2002 | EP0938505B1 Anti-endoglin monoclonal antibodies and their use in anti-angiogenesis therapy |
| 03/06/2002 | EP0848757B1 The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells |
| 03/06/2002 | EP0703784B1 Release and mobilisation of haematopoietic cells |
| 03/06/2002 | CN1339068A Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 03/06/2002 | CN1339064A Antibody binding to human airway trypsin-like enzyme and utilization thereof |
| 03/06/2002 | CN1339032A Reverse hydroxamate inhibitors of matrix metalloproteinases |
| 03/06/2002 | CN1339028A Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 03/06/2002 | CN1338958A The use of 4-H-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 03/06/2002 | CN1338941A High molecular weight extracts of 1 (convolvulus arvensis) (field bindweed) |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338932A Use of lipoic acid combination with ascorbic acid in the treatment of cancer |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338457A 3 alpha-bromoepipodophyllotoxin, its position-4 substituted derivative and preparing process thereof |
| 03/06/2002 | CN1338456A Benzodiazapine compounds containing imidazole propanamido and its preparing process and application |
| 03/06/2002 | CN1338311A Nm-class preparation of liver target recombinant EGFP-ATK plasmid |
| 03/06/2002 | CN1338304A Health-care 'Genoderma King' |
| 03/06/2002 | CN1338284A 复方鲨鱼软骨素 Complex Shark Cartilage |
| 03/06/2002 | CN1338260A Medicine for treating cancers |
| 03/06/2002 | CN1338256A Anticancer compound and its application |
| 03/06/2002 | CN1080311C Peptide related to human programmed cell death and DNA cencoding it |
| 03/06/2002 | CN1080260C Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 03/06/2002 | CN1080256C Beta-lactams, methods for preparation of taxanes and sidechain-bearing taxanes |
| 03/06/2002 | CN1080117C Treamtent of tumors with compounds having RXR retinoid receptor agonist activity |
| 03/06/2002 | CN1080115C Elemi olefine injecta and its preparation |
| 03/06/2002 | CN1080113C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353089 Stimulating proliferation of cytotoxic lymphocytes cells by exposing a fluid sample with a major histocompatability complex and incubate to allow lysis of the presenting cells |
| 03/05/2002 | US6353055 Polycation homopolymer or copolymer |
| 03/05/2002 | US6353019 Anticancer drugs |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6352996 Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
| 03/05/2002 | US6352844 Ceramide generating retinoids and inhibitors of tumors |
| 03/05/2002 | US6352682 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/05/2002 | CA2072606C Herbal treatment of malignancy |
| 03/05/2002 | CA2056638C 2 .beta., 19-ethylene bridged steroids as aromatase inhibitors |
| 02/28/2002 | WO2002016965A2 Radioactive emission detector |
| 02/28/2002 | WO2002016939A2 Methods of diagnosis of cancer and screening for cancer modulators |
| 02/28/2002 | WO2002016615A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 02/28/2002 | WO2002016608A1 New sequences |
| 02/28/2002 | WO2002016602A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016597A2 Lipid metabolism enzymes |
| 02/28/2002 | WO2002016587A2 Microtubule-associated proteins and tubulins |
| 02/28/2002 | WO2002016575A1 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016559A2 In vivo animal model of human leukemia |
| 02/28/2002 | WO2002016438A2 Synthesis of complex carbohydrates |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016413A2 Cripto tumour polypeptide |
| 02/28/2002 | WO2002016407A2 Sh2 domain binding inhibitors |
| 02/28/2002 | WO2002016401A2 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 02/28/2002 | WO2002016395A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv |
| 02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016382A1 Improved specificity in treatment of diseases |
| 02/28/2002 | WO2002016376A1 Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 02/28/2002 | WO2002016368A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | WO2002016365A1 Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity |
| 02/28/2002 | WO2002016362A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016361A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016360A2 Nitrogenous heterocyclic compounds |
| 02/28/2002 | WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | WO2002016352A1 Quinazoline derivatives |
| 02/28/2002 | WO2002016351A1 Quinazoline derivatives as kinase inhibitors |
| 02/28/2002 | WO2002016348A1 Antiangiogenic bicyclic derivatives |
| 02/28/2002 | WO2002016340A1 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016339A1 Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016338A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 02/28/2002 | WO2002016326A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 02/28/2002 | WO2002016316A1 10-ARYL-11-HBENZO [b]FLUORENE DERIVATIVES AND ANALOGS FOR MEDICINAL USE |
| 02/28/2002 | WO2002016315A1 Aza-amino acid derivatives (factor xa-inhibitors 15) |
| 02/28/2002 | WO2002016311A1 Carboxylic acid derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 02/28/2002 | WO2002016310A1 Selective androgen receptor modulators and methods of use thereof |
| 02/28/2002 | WO2002015925A1 Methof of regulating apoptosis and apoptosis-regulatory polypeptide |
| 02/28/2002 | WO2002015924A1 Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer |
| 02/28/2002 | WO2002015921A2 Methods of treating cutaneous and peripheral t-cell lymphoma by a histone deacetylase inhibitor |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015917A1 Use of agaricus blazei murill to prevent or treat skin and other disorders |
| 02/28/2002 | WO2002015916A1 Use of dihydroboswellic acids or hydrogenated extracts of boswellia for prophylactic and/or therapeutic treatment |
| 02/28/2002 | WO2002015915A2 Method for inducing an anti-tumor and anti-cachexia immune response in mammals |